Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Top Five Pharma Stories Of 2022

29 Dec 2022

• By Kevin Grogan

Person's hand scrolling on tablet screen, news concept — Major Story Topics Ranged From The Rise of mRNA To The Obesity Boom • Source: Shutterstock

Related Content

Lilly CEO: Realistic Expectations Needed For Current Wave of Alzheimer’s Treatments

01 Dec 2022

Merck KGaA Exec On Gearing For mRNA Prime Time, De-Risking Manufacturing

14 Nov 2022

Roche’s Alzheimer’s Drug Fails In Phase III Giving Eisai/Biogen A Clear Run

14 Nov 2022

Clovis Close To Bankruptcy As Cancer Drug Outlook Worsens

10 Nov 2022

Novo Targets Teens With Wegovy As It Heads Off Lilly Mounjaro Threat

07 Nov 2022

BioNTech Bolsters Cancer Immunotherapy Ambitions In Pact With Cash-Poor Ryvu

30 Nov 2022

Pfizer Leads Big Pharma M&A In 2022 – But Is There More To Come?

12 Oct 2022

Zest Is Back At Zealand With Cash Injection And A Clinical Win

05 Oct 2022

Lilly Preparing For Increasing Mounjaro Demand On Top Of Solid Launch

01 Nov 2022

Finance Watch: Recent M&A Uptick Gives Biopharma A Needed Boost

21 Jul 2022

Novo Nordisk’s New Diabetes Combo Shows Potential To Best Lilly’s Mounjaro

23 Aug 2022

How Biogen’s Aduhelm Bet Became A Commercial Bust

06 Jun 2022

Novartis To Cut 8,000 Jobs In Global Restructure

29 Jun 2022

Pfizer's Plan To Establish A $6bn Migraine Franchise

14 Dec 2022

Moderna Chalks Up Industry Milestone With mRNA Cancer Vaccine Efficacy Success

14 Dec 2022

Amgen To Enhance Rare Disease Franchise With $27.8bn Horizon Takeover

12 Dec 2022

Early Data On Amgen’s AMG 133 Show Potential Durability, Dosing Advantage In Obesity

05 Dec 2022

Big Pharma Restructures Commercial Teams In India

06 Dec 2022

Lecanemab Set A New Bar In Alzheimer’s, Now Many Drugs Are Seeking To Raise It

16 Dec 2022

RNA Medicines: Advancements Leading To Investments

01 Dec 2022

Related Companies

Biogen, Inc.

Eisai Co., Ltd.

Roche Holding AG

Eli Lilly and Company

Novo Nordisk A/S

Amgen, Inc.

Pfizer Inc.

Horizon Therapeutics plc

Sanofi

Johnson & Johnson

ChemoCentryx, Inc.

Biohaven Pharmaceutical Holding Company Ltd.

BioNTech SE

Moderna, Inc.

Merck & Co., Inc.

Ryvu Therapeutics

Clovis Oncology, Inc.

Novartis AG

Zealand Pharma A/S

Additional Topics

M & A Restructuring Personalized Medicine Research & Development Scrip Perspectives Neurology Metabolic Disorders BioPharmaceutical

More from Scrip Perspectives

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.